When will the FDA approve Intellia Therapeutics' lonvo-z?

Begins in 377 days · Jun 30, 12:00am EDT

$2,700 vol

ALL

Chance

Before July 2027

37%

▲ 10

Before July 2027

▲ 10

Before October 2027

▼ 1

Before October 2027

▼ 1

Before 2028

▼ 1

Before 2028

▼ 1

Before July 2027

Resolves Yes if the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027.Outcome verified from U.S. Food and Drug Administration., FDA, and Intellia Therapeutics.

Timeline and payout

Market openMar 24, 2026 · 10:00am EDT

Market closesAfter the outcome occurs

Projected payout30 minutes after closing

This market will close and expire early if the event occurs. Otherwise, it closes by Jun 30, 2027 at 11:59pm EDT.

SeriesKXFDAAPPROVALDATENTLA

EventKXFDAAPPROVALDATENTLA-LONV

MarketKXFDAAPPROVALDATENTLA-LONV-27JUL01

Insider trading is prohibited

The following are prohibited from trading this contract:

Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.